Workflow
Diagnostics
icon
搜索文档
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Globenewswire· 2025-11-04 05:01
Mdxhealth to Release Third Quarter 2025 Financial Resultson November 12 Company to Host Conference Call with Live Q&A, November 12, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – November 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the third quarter ended September 30, 2025, after market close on Wednesday, November 12, 2025. Title:Mdxhealth Presents Third Quarter 2025 Financial Results andCorp ...
Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts
Seeking Alpha· 2025-10-31 23:09
Guardant Health, Inc. ( GH ) is a cancer genomics diagnostics company. GH leverages the SMART platform, which spans screening, therapy selection, minimal residual disease (MRD), and surveillance across all stages of cancer. GH’s business segments include Oncology as the anchor, Screening, and Biopharma & Data. InMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science f ...
Guardant Health Stock Soars On Strong Q3 Results, Upbeat FY 2025 Outlook
RTTNews· 2025-10-30 20:47
Shares of Guardant Health Inc. (GH) are up over 25% at $90 in premarket trading on Thursday, after the company reported exceptionally strong financial results for the quarter ended September 30, 2025, and raised its full-year 2025 outlook.This commercial-stage precision oncology company Guardant360 Liquid test and Guardant360 CDx test, the first comprehensive liquid biopsy test approved by the FDA to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection w ...
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
Prnewswire· 2025-10-30 20:01
Following the conclusion of the conference call, a replay will be available for 30 days on the investor relations section of the Company's website at pavmed.com. About PAVmedPAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal ...
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
Globenewswire· 2025-10-30 18:17
Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher ScientificLOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. Gary Pestano, C ...
OPKO Health(OPK) - 2025 Q3 - Earnings Call Transcript
2025-10-30 05:30
OPKO Health (NasdaqGS:OPK) Q3 2025 Earnings Call October 29, 2025 04:30 PM ET Speaker5Good afternoon and welcome to the OPKO Health third quarter 2025 financial results conference call. All participants will be in listen-only mode. Should you need assistance during the conference call, you may signal an operator by pressing star followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad. To withdraw yo ...
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
Globenewswire· 2025-10-29 19:30
BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET on November 5, 2025. A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 1 ...
BillionToOne Announces Launch of Initial Public Offering Roadshow
Globenewswire· 2025-10-29 18:00
MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that it has launched the roadshow for its proposed initial public offering of 3,846,000 shares of its Class A common stock. In addition, BillionToOne intends to grant the underwriters a 30-day option to purchase up to an additional 576,900 shares of its Class A common stock at the initial public offering pri ...
US Stock Market top gainers and losers on October 28: ReNew Energy Global sees 240% jump, Co-Diagnostics, Inc plunges; here’s how NASDAQ, Dow Jones, S&P 500 performed
The Economic Times· 2025-10-29 10:26
(Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. ...
Gold Falls 3%; Carter's Shares Gain After Q3 Earnings - BIO-key International (NASDAQ:BKYI), Co-Diagnostics (NASDAQ:CODX)
Benzinga· 2025-10-28 01:03
美股市场表现 - 道琼斯指数上涨051%至47,44922点,涨幅超过200点 [1] - 纳斯达克指数上涨168%至23,59380点 [1] - 标普500指数上涨101%至6,86011点 [1] - 通信服务板块领涨,涨幅达15% [1] - 公用事业板块下跌04% [1] 个股重大变动 - Carter's Inc (CRI) 股价上涨5%,公司第三季度每股收益074美元,超出分析师共识估计073美元,季度销售额757836百万美元,低于分析师共识估计769763百万美元 [2] - Sotherly Hotels Inc (SOHO) 股价飙升137%至215美元,公司同意被Kemmons Wilson Hospitality Partners LP附属公司牵头的合资企业收购 [7] - Co-Diagnostics, Inc (CODX) 股价大涨102%至07104美元,公司与Arabian Eagle签署最终协议,共同成立CoMira Diagnostics [7] - BIO-key International, Inc (BKYI) 股价上涨115%至16750美元,公司与斯堪的纳维亚主要IT安全分销商IT2Trust建立合作伙伴关系 [7] - Intellia Therapeutics, Inc (NTLA) 股价下跌43%至1471美元,公司宣布暂时停止对Nex-z药物的MAGNITUDE和MAGNITUDE-2三期临床研究进行患者给药和筛查 [7] - Organon & Co (OGN) 股价下跌20%至729美元,公司首席执行官Kevin Ali因审计委员会调查而辞职 [7] - Genenta Science SpA (GNTA) 股价下跌43%至35268美元,公司宣布定价1500万美元的美国存托凭证定向增发 [7] 商品市场 - 原油价格上涨01%至6158美元 [6] - 黄金价格下跌31%至4,00990美元 [6] - 白银价格下跌38%至46755美元 [6] - 铜价格上涨09%至51690美元 [6] 全球其他市场 - 欧洲斯托克600指数上涨017%,西班牙IBEX 35指数上涨082%,英国富时100指数上涨015%,德国DAX指数上涨016%,法国CAC 40指数上涨007% [7][8] - 日本日经225指数上涨246%,香港恒生指数上涨105%,中国上证综指上涨118%,印度孟买Sensex指数上涨067% [9] 公司财报与展望 - Carter's Inc 预计新行政关税将带来重大财务影响,年度化税前收益影响约为2亿至25亿美元,高于2024财年支付的11亿美元关税 [2][3] 经济数据 - 达拉斯联储制造业指数将于当日发布 [10]